| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $126.0M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 20,000 | $9.97 | $199,400.00 | +0.5% | +138.7% | +155.5% | |
| Apr 24, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 20,000 | $10.23 | $204,640.10 | +0.3% | +138.4% | +144.1% | |
| Apr 19, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 29,400 | $10.56 | $310,390.50 | +0.8% | +135.3% | +122.4% | |
| Mar 28, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 50,000 | $12.82 | $641,000.00 | +1.4% | +61.3% | +98.1% | |
| Mar 20, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 50,600 | $9.65 | $488,290.00 | +1.4% | +67.8% | +167.0% | |
| Nov 15, 2023 | HROW Harrow, Inc. | 10% Owner | Buy | 25,000 | $8.03 | $200,735.00 | +0.7% | +42.1% | +429.1% | |
| Sep 20, 2023 | HROW Harrow, Inc. | 10% Owner | Buy | 20,000 | $14.60 | $292,076.29 | +0.3% | -28.7% | +228.4% | |
| Dec 30, 2022 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 15,473 | $2.71 | $41,948.85 | -0.6% | +15.1% | -30.0% | |
| Dec 14, 2022 | HROW Harrow, Inc. | 10% Owner | Buy | 431,183 | $10.52 | $4,536,045.16 | +12.9% | +46.8% | -22.6% | |
| Nov 3, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 20,262 | $7.81 | $158,284.72 | +1.0% | +45.9% | -26.0% |